Estimates Revisions Zydus Lifesciences Limited

Equities

Market Closed - NSE India S.E. Other stock markets 06:49:39 2025-01-17 am EST			5-day change	1st Jan Change
994.65 ^INR	+0.66%		-0.97%	+2.36%

Jan. 18	Zydus Lifesciences Receives Approval from USFDA to Conduct Phase II(B) Clinical Trial for Usnoflast	CI
Jan. 10	Nomura Upgrades Zydus Lifesciences to Buy From Neutral, Adjusts Price Target to INR1,140 From INR1,030	MT

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. EPS revision	1m. Revenue rev.	1y. EPS revision	1y. Revenue rev.
	ZYDUS LIFESCIENCES LIMITED
	SUN PHARMACEUTICAL INDUSTRIES LTD.
	OTSUKA HOLDINGS CO., LTD.
	SANDOZ GROUP AG
	CIPLA LIMITED
	ONO PHARMACEUTICAL CO., LTD.
	GEDEON RICHTER
	GLENMARK PHARMACEUTICALS LIMITED
	Average
	Weighted average by Cap.